Cargando…

Development of Rift Valley fever (RVF) vaccine by genetic joining of the RVF-glycoprotein Gn with the strong adjuvant subunit B of cholera toxin (CTB) and expression in bacterial system

One of the mosquito-borne zoonotic diseases is the Rift Valley fever virus (RVFV). Currently, there is no completely licensed vaccine that can be used to vaccinate animals or humans outside endemic areas. The aim of this work was to use the RVFV glycoprotein (Gn) and the subunit B of cholera toxin (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ibrahim, Essam H., Taha, Ramadan, Ghramh, Hamed A., Kilany, Mona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6864185/ https://www.ncbi.nlm.nih.gov/pubmed/31762643 http://dx.doi.org/10.1016/j.sjbs.2018.08.019

Ejemplares similares

Theoretical risk of genetic reassortment should not impede development of live, attenuated Rift Valley fever (RVF) vaccines commentary on the draft WHO RVF Target Product Profile
por: Monath, Thomas P., et al.
Publicado: (2020)

Safety and efficacy of ChAdOx1 RVF vaccine against Rift Valley fever in pregnant sheep and goats
por: Stedman, Anna, et al.
Publicado: (2019)

Rift valley fever (RVF) viral zoonotic disease steadily circulates in the Mauritanian animals and humans: A narrative review
por: Mohapatra, Ranjan K., et al.
Publicado: (2023)

Enhanced surveillance for Rift Valley Fever in livestock during El Niño rains and threat of RVF outbreak, Kenya, 2015-2016
por: Oyas, Harry, et al.
Publicado: (2018)

Rift Valley fever (RVF): a re-emerging zoonotic disease, pathogenesis, epidemiology, current status, and future perspective – correspondence
por: Akash, Shopnil, et al.
Publicado: (2023)

Active Surveillance in the investigation and analysis of RVF in Western and Central Uganda
por: Nanfuka, Mary L., et al.
Publicado: (2019)

Trapping of Rift Valley Fever (RVF) vectors using Light Emitting Diode (LED) CDC traps in two arboviral disease hot spots in Kenya
por: Tchouassi, David P, et al.
Publicado: (2012)

An adenovirus-vectored RVF vaccine confers complete protection against lethal RVFV challenge in A129 mice
por: Hao, Meng, et al.
Publicado: (2023)

Mutational Analysis of the Rift Valley Fever Virus Glycoprotein Precursor Proteins for Gn Protein Expression
por: Phoenix, Inaia, et al.
Publicado: (2016)

Naturally Acquired Rift Valley Fever Virus Neutralizing Antibodies Predominantly Target the Gn Glycoprotein
por: Wright, Daniel, et al.
Publicado: (2020)

A Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Confers Full Protection against Rift Valley Fever Challenge in Sheep
por: Faburay, Bonto, et al.
Publicado: (2016)

Cell type and receptor identity regulate cholera toxin subunit B (CTB) internalization
por: Sethi, Anirudh, et al.
Publicado: (2019)

Two monoclonal antibodies against glycoprotein Gn protect mice from Rift Valley Fever challenge by cooperative effects
por: Gutjahr, Benjamin, et al.
Publicado: (2020)

N-Glycans on the Rift Valley Fever Virus Envelope Glycoproteins Gn and Gc Redundantly Support Viral Infection via DC-SIGN
por: Phoenix, Inaia, et al.
Publicado: (2016)

Vaccine Efficacy of Self-Assembled Multimeric Protein Scaffold Particles Displaying the Glycoprotein Gn Head Domain of Rift Valley Fever Virus
por: Wichgers Schreur, Paul J., et al.
Publicado: (2021)

Characterization of Two Neutralizing Antibodies against Rift Valley Fever Virus Gn Protein
por: Hao, Meng, et al.
Publicado: (2020)

Intracellular Expression of CTB in Vibrio cholerae Strains in Laboratory Culture Conditions
por: Choi, Hunseok, et al.
Publicado: (2023)

Study of anticancer, antimicrobial, immunomodulatory, and silver nanoparticles production by Sidr honey from three different sources
por: Ghramh, Hamed A., et al.
Publicado: (2019)

Development of in-house ELISAs for the detection of anti-SARS‑CoV‑2 RBD and N IgG and IgM antibodies in biological samples
por: Ibrahim, Essam H., et al.
Publicado: (2021)

Development of rapid and cost-effective top-loading device for the detection of anti-SARS-CoV-2 IgG/IgM antibodies
por: Ibrahim, Essam H., et al.
Publicado: (2021)

Evaluation of TcpF-A2-CTB Chimera and Evidence of Additive Protective Efficacy of Immunizing with TcpF and CTB in the Suckling Mouse Model of Cholera
por: Price, Gregory A., et al.
Publicado: (2012)

Expression and functional validation of heat-labile enterotoxin B (LTB) and cholera toxin B (CTB) subunits in transgenic rice (Oryza sativa)
por: Soh, Ho Seob, et al.
Publicado: (2015)

The Pathogenesis of Rift Valley Fever
por: Ikegami, Tetsuro, et al.
Publicado: (2011)

Rift Valley Fever Encephalitis
por: Alrajhi, Abdulrahman A., et al.
Publicado: (2004)

Rift Valley Fever in Chad
por: Ringot, David, et al.
Publicado: (2004)

Vaccination with DNA Plasmids Expressing Gn Coupled to C3d or Alphavirus Replicons Expressing Gn Protects Mice against Rift Valley Fever Virus
por: Bhardwaj, Nitin, et al.
Publicado: (2010)

Preliminary Evaluation of a Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Providing Full Protection against Heterologous Virulent Challenge in Cattle
por: Wilson, William C., et al.
Publicado: (2021)

Antibody profile in symptomatic/asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected Saudi persons
por: Ibrahim, Essam H., et al.
Publicado: (2021)

Rift Valley Fever in Goats, Cameroon
por: LeBreton, Matthew, et al.
Publicado: (2006)

RIFT VALLEY FEVER: LESSONS TO BE LEARNED
por: Alam, Awatif A., et al.
Publicado: (2000)

Rift Valley Fever in Namibia, 2010
por: Monaco, Federica, et al.
Publicado: (2013)

A Rift Valley fever virus Gn ectodomain-based DNA vaccine induces a partial protection not improved by APC targeting
por: Chrun, Tiphany, et al.
Publicado: (2018)

Bacterium-Like Particles Displaying the Rift Valley Fever Virus Gn Head Protein Induces Efficacious Immune Responses in Immunized Mice
por: Zhang, Shengnan, et al.
Publicado: (2022)

The 2007 Rift Valley Fever Outbreak in Sudan
por: Hassan, Osama Ahmed, et al.
Publicado: (2011)

Rift Valley Fever, Mayotte, 2007–2008
por: Sissoko, Daouda, et al.
Publicado: (2009)

Molecular Biology of Rift Valley Fever Virus
por: Bouloy, Michele, et al.
Publicado: (2010)

Rift Valley Fever Potential, Arabian Peninsula
por: Anyamba, Assaf, et al.
Publicado: (2006)

Molecular Epidemiology of Rift Valley Fever Virus
por: Grobbelaar, Antoinette A., et al.
Publicado: (2011)

An Assembly Model of Rift Valley Fever Virus
por: Rusu, Mirabela, et al.
Publicado: (2012)

Rift Valley Fever, Sudan, 2007 and 2010
por: Aradaib, Imadeldin E., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fu0epk4q3kbv6rm6lnalofjj0b